Part D/Prescription Drugs

Where’s the Patient in the Equation?

In response to rising cost of prescription drugs, a handful of organizations have developed frameworks for assessing the value of therapies and compare them to treatment cost. So how will these “value frameworks” affect the patient-physician decision making? Read article here……

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.